ES2607490T3 - Péptidos antienvejecimiento activadores del proteasoma y composiciones que los contienen - Google Patents
Péptidos antienvejecimiento activadores del proteasoma y composiciones que los contienen Download PDFInfo
- Publication number
- ES2607490T3 ES2607490T3 ES10715914.7T ES10715914T ES2607490T3 ES 2607490 T3 ES2607490 T3 ES 2607490T3 ES 10715914 T ES10715914 T ES 10715914T ES 2607490 T3 ES2607490 T3 ES 2607490T3
- Authority
- ES
- Spain
- Prior art keywords
- group
- general formula
- amino acid
- substituted
- zero
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 2
- 102000004245 Proteasome Endopeptidase Complex Human genes 0.000 title 1
- 108090000708 Proteasome Endopeptidase Complex Proteins 0.000 title 1
- 230000003213 activating effect Effects 0.000 title 1
- 230000003712 anti-aging effect Effects 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- 102000004196 processed proteins & peptides Human genes 0.000 title 1
- 125000000217 alkyl group Chemical group 0.000 abstract 2
- 235000001014 amino acid Nutrition 0.000 abstract 2
- 229940024606 amino acid Drugs 0.000 abstract 2
- 150000001413 amino acids Chemical class 0.000 abstract 2
- 125000006239 protecting group Chemical group 0.000 abstract 2
- 125000001433 C-terminal amino-acid group Chemical group 0.000 abstract 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 abstract 1
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 abstract 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 abstract 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 abstract 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 abstract 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 abstract 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 abstract 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 abstract 1
- 125000001429 N-terminal alpha-amino-acid group Chemical group 0.000 abstract 1
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 abstract 1
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 abstract 1
- 239000004473 Threonine Substances 0.000 abstract 1
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 abstract 1
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 abstract 1
- 125000000539 amino acid group Chemical group 0.000 abstract 1
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 abstract 1
- 125000001584 benzyloxycarbonyl group Chemical group C(=O)(OCC1=CC=CC=C1)* 0.000 abstract 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 235000018417 cysteine Nutrition 0.000 abstract 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 abstract 1
- 125000000151 cysteine group Chemical group N[C@@H](CS)C(=O)* 0.000 abstract 1
- 235000013922 glutamic acid Nutrition 0.000 abstract 1
- 239000004220 glutamic acid Substances 0.000 abstract 1
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 abstract 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 abstract 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 abstract 1
- 229960000310 isoleucine Drugs 0.000 abstract 1
- 229930182817 methionine Natural products 0.000 abstract 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 abstract 1
- 150000003141 primary amines Chemical group 0.000 abstract 1
- 238000006467 substitution reaction Methods 0.000 abstract 1
- 125000002088 tosyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1C([H])([H])[H])S(*)(=O)=O 0.000 abstract 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 abstract 1
- 239000004474 valine Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1002—Tetrapeptides with the first amino acid being neutral
- C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
- C07K5/101—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms, e.g. Val, Ile, Leu
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/16—Emollients or protectives, e.g. against radiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1019—Tetrapeptides with the first amino acid being basic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/52—Stabilizers
- A61K2800/522—Antioxidants; Radical scavengers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Biochemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Dermatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Toxicology (AREA)
- Peptides Or Proteins (AREA)
- Cosmetics (AREA)
Abstract
Compuesto peptídico de la siguiente fórmula general (I): R1 - X1 - Arg - Lys - Gly - X2 - R2 En la cual, X1 representa una isoleucina, una leucina, una prolina, una valina, o es igual a cero, X2 representa una cisteína, un ácido glutámico, una glutamina, una histidina, una metionina, una fenilalanina, una tirosina, una treonina, o es igual a cero, R1 representa la función amina primaria del aminoácido N-terminal, libre o sustituida por un grupo protector que puede seleccionarse de entre un grupo acetilo, un grupo benzoílo, un grupo tosilo o un grupo benciloxicarbonilo, R2 representa el grupo hidroxilo de la función carboxilo del aminoácido C-terminal, sustituido por un grupo protector que puede seleccionarse de entre una cadena alquilo de C1 a C20, o un grupo NH2, NHY o NYY en el que Y representa una cadena alquilo de C1 a C4, estando constituida dicha secuencia de formula general (I) por 3 a 5 residuos de aminoácidos, pudiendo comprender dicha secuencia de fórmula general (1) sustituciones de los aminoácidos X1 y X2, por otros aminoácidos químicamente equivalentes.
Description
Claims (1)
-
imagen1 imagen2
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0901612A FR2944016B1 (fr) | 2009-04-02 | 2009-04-02 | Nouveaux peptides anti-age activateurs du proteasome et compositions les contenant |
| FR0901612 | 2009-04-02 | ||
| PCT/FR2010/000279 WO2010112712A2 (fr) | 2009-04-02 | 2010-04-01 | Nouveaux peptides anti-age activateurs du proteasome et compositions les contenant |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2607490T3 true ES2607490T3 (es) | 2017-03-31 |
Family
ID=41557616
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES10715914.7T Active ES2607490T3 (es) | 2009-04-02 | 2010-04-01 | Péptidos antienvejecimiento activadores del proteasoma y composiciones que los contienen |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US8883734B2 (es) |
| EP (1) | EP2413891B1 (es) |
| ES (1) | ES2607490T3 (es) |
| FR (1) | FR2944016B1 (es) |
| WO (1) | WO2010112712A2 (es) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8193155B2 (en) | 2009-02-09 | 2012-06-05 | Elc Management, Llc | Method and compositions for treating skin |
| KR20190125534A (ko) * | 2012-09-14 | 2019-11-06 | 이엘씨 매니지먼트 엘엘씨 | 케라틴 표면의 세포에서 선택적 카타볼리시스를 개선하는 방법 및 조성물 |
| US10383815B2 (en) | 2012-09-14 | 2019-08-20 | Elc Management Llc | Method and compositions for improving selective catabolysis in cells of keratin surfaces |
| WO2014125376A2 (en) * | 2013-02-15 | 2014-08-21 | Mediterranean Institute For Life Sciences | Protein damage in aging and age-related diseases |
| CN104139573A (zh) * | 2014-08-07 | 2014-11-12 | 镇江洋溢汽车部件有限公司 | 一种玻璃钢复合板 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3100005B2 (ja) * | 1992-07-28 | 2000-10-16 | 雪印乳業株式会社 | ヒト免疫不全ウィルス感染・増殖抑制剤 |
| FR2822701B1 (fr) | 2001-04-03 | 2005-03-18 | Lvmh Rech | Utilisation d'un extrait d'algue phaeodactylum comme agent cosmetique favorisant l'activite du proteasome des cellules de la peau et composition cosmetique le contenant |
| US20050214890A1 (en) * | 2003-11-26 | 2005-09-29 | Zhiqun Tan | Novel "Cleave-N-Read" system for protease activity assay and methods of use thereof |
| FR2864085B1 (fr) * | 2003-12-18 | 2010-09-17 | Centre Nat Rech Scient | Nouveaux modulateurs du proteasome |
| CA2590177A1 (en) * | 2004-12-10 | 2006-06-15 | Protemix Corporation Limited | Glyponectin (glycosylated adiponectin) for the treatment of diseases and conditions |
| CA2604133C (en) | 2005-04-07 | 2015-12-01 | Centre National De La Recherche Scientifique | Compounds useful as modulators of the proteasome activity |
| ES2573027T3 (es) | 2006-05-17 | 2016-06-03 | F. Hoffmann-La Roche Ag | Células productoras de polipéptido |
| KR20090053752A (ko) * | 2006-06-01 | 2009-05-27 | 데라퓨틱 펩타이즈, 인코포레이션 | 중합성 생계면활성제 |
-
2009
- 2009-04-02 FR FR0901612A patent/FR2944016B1/fr not_active Expired - Fee Related
-
2010
- 2010-04-01 EP EP10715914.7A patent/EP2413891B1/fr active Active
- 2010-04-01 WO PCT/FR2010/000279 patent/WO2010112712A2/fr active Application Filing
- 2010-04-01 US US13/262,481 patent/US8883734B2/en active Active
- 2010-04-01 ES ES10715914.7T patent/ES2607490T3/es active Active
Also Published As
| Publication number | Publication date |
|---|---|
| FR2944016A1 (fr) | 2010-10-08 |
| US20120027703A1 (en) | 2012-02-02 |
| EP2413891A2 (fr) | 2012-02-08 |
| WO2010112712A3 (fr) | 2010-11-25 |
| EP2413891B1 (fr) | 2016-09-21 |
| WO2010112712A2 (fr) | 2010-10-07 |
| US8883734B2 (en) | 2014-11-11 |
| FR2944016B1 (fr) | 2012-03-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2607490T3 (es) | Péptidos antienvejecimiento activadores del proteasoma y composiciones que los contienen | |
| ES2526292T3 (es) | Antagonistas de la somatostatina selectivos para receptor (SSTR2) | |
| ES2528346T3 (es) | Derivado de péptido insulinotrópico en el que se ha modificado su aminoácido N-terminal | |
| ES2585580T3 (es) | Péptidos novedosos antienvejecimiento y composición cosmética y/o farmacéutica que los contiene | |
| ES2512141T3 (es) | Análogo peptídico de oxintomodulina | |
| ES2545607T3 (es) | Antígenos de la gripe recombinantes solubles | |
| ES2558330T3 (es) | Péptido WT1 restringido por HLA-A*3303 y composición farmacéutica que comprende el mismo | |
| ES2559062T3 (es) | Método para la activación de linfocitos T colaboradores y composición para su uso en el método | |
| ES2616658T3 (es) | Péptidos que mimetizan el factor de crecimiento y sus usos | |
| RU2013156600A (ru) | Стабилизированные жидкие ферментные композиции | |
| JP2014224126A5 (es) | ||
| MX381014B (es) | Uso de tripeptidil-peptidasas que toleran la prolina en composiciones de un aditivo para piensos. | |
| CL2013003416A1 (es) | Secuencia de peptidos quiméricos que comprende dsspl o dasph composiciones , usos y metodo para mejorar metabolismo de glucosa. | |
| CO6190536A2 (es) | Vacunas peptidicas para canceres que expresan antigenos asociados con tumores | |
| RU2014148530A (ru) | Производные дипептида лизин-глутаминовая кислота | |
| ECSP19003047A (es) | Nuevos análogos de urocortina-2 modificados con ácido graso para el tratamiento de diabetes y enfermedad renal crónica | |
| CO6260099A2 (es) | Depsipeptidos ciclicos | |
| GT200900163A (es) | Nuevos compuestos y sus efectos sobre el conductismo de la alimentacion. | |
| RU2012102050A (ru) | Композиции для восстановления кожи, содержащие активаторы циркадных генов и синергическую комбинацию активаторов гена sirt1 | |
| ES2547528T3 (es) | Polipéptidos de cetorreductasa para la producción de acetidinona | |
| RU2013102991A (ru) | Связанные с дипептидом лекарственные средства | |
| AR067701A1 (es) | Metodos y composiciones utiles para la preparacion de inhibidores del contransportador de sodio y glucosa 2 | |
| RU2013103093A (ru) | Пептидные пролекарства, принадлежащие к суперсемейству амид-содержащих глюкаганов | |
| MX2012003398A (es) | Agonistas npr-b novedosos. | |
| MX2018000697A (es) | Peptidos anti-inflamatorios y usos de los mismos. |